1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Lyme Disease Diagnostics Market
2.2. Global Lyme Disease Diagnostics Market, By Diagnostic Test, 2023 (US$ Million)
2.3. Global Lyme Disease Diagnostics Market, By Sample, 2023 (US$ Million)
2.4. Global Lyme Disease Diagnostics Market, By End-User, 2023 (US$ Million)
2.5. Global Lyme Disease Diagnostics Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023

3. Lyme Disease Diagnostics Market: Competitive Analysis
3.1. Market Positioning of Key Lyme Disease Diagnostics Market Vendors
3.2. Strategies Adopted by Lyme Disease Diagnostics Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032

4. Lyme Disease Diagnostics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Lyme Disease Diagnostics Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Serological Test
5.3.1.1. ELISA
5.3.1.2. Western Blot
5.3.2. Polymerase Chain Reaction (PCR) Test
5.3.3. Others (Culture Test, Antigen Test, etc.)

6. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Blood
6.3.2. Cerebrospinal Fluid (CSF)
6.3.3. Others (Joint Fluid, Urine, etc.)

7. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Hospitals
7.3.2. Diagnostic Laboratories
7.3.3. Others (Clinics, Research Institutes, etc.)


8. North America Lyme Disease Diagnostics Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
8.3. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
8.4. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
8.5.Lyme Disease Diagnostics Market: By Region, 2022-2032, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
8.5.1.1.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
8.5.1.1.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
8.5.1.2.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
8.5.1.2.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
8.5.1.3.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
8.5.1.3.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)

9. UK and European Union Lyme Disease Diagnostics Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
9.3. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
9.4. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
9.5.Lyme Disease Diagnostics Market: By Region, 2022-2032, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
9.5.1.1.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
9.5.1.1.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
9.5.1.2.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
9.5.1.2.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
9.5.1.3.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
9.5.1.3.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
9.5.1.4.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
9.5.1.4.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
9.5.1.5.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
9.5.1.5.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
9.5.1.6.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
9.5.1.6.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)

10. Asia Pacific Lyme Disease Diagnostics Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
10.3. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
10.4. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
10.5.Lyme Disease Diagnostics Market: By Region, 2022-2032, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
10.5.1.1.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
10.5.1.1.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
10.5.1.2.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
10.5.1.2.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
10.5.1.3.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
10.5.1.3.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
10.5.1.4.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
10.5.1.4.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
10.5.1.5.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
10.5.1.5.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
10.5.1.6.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
10.5.1.6.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)

11. Latin America Lyme Disease Diagnostics Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
11.3. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
11.4. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
11.5.Lyme Disease Diagnostics Market: By Region, 2022-2032, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
11.5.1.1.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
11.5.1.1.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
11.5.1.2.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
11.5.1.2.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
11.5.1.3.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
11.5.1.3.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)

12. Middle East and Africa Lyme Disease Diagnostics Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
12.3. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
12.4. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
12.5.Lyme Disease Diagnostics Market: By Region, 2022-2032, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
12.5.1.1.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
12.5.1.1.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
12.5.1.2.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
12.5.1.2.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Lyme Disease Diagnostics Market: By Diagnostic Test, 2022-2032, USD (Million)
12.5.1.3.2. Lyme Disease Diagnostics Market: By Sample, 2022-2032, USD (Million)
12.5.1.3.3. Lyme Disease Diagnostics Market: By End-User, 2022-2032, USD (Million)

13. Company Profile
13.1. DiaSorin S.p.A
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. bioMerieux SA
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Quidel Corporation
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. LabCorp
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Quest Diagnostics
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Abbott Laboratories
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Bio-Rad Laboratories, Inc.
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. DiaSorin S.p.A
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. T2 Biosystems, Inc.
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. F. Hoffmann-La Roche AG
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Meridian Bioscience, Inc.
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. Thermo Fisher Scientific Inc.
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
13.13. Other Notable Players
13.13.1. Company Overview
13.13.2. Financial Performance
13.13.3. Product Portfolio
13.13.4. Strategic Initiatives